Scientists found that anxiety disorders share one hidden brain chemistry difference and it points to a nutrient most people are not getting enough

Anxiety has been explained to most people as a psychological problem. Too much stress. A nervous temperament. A brain that overestimates threat and underestimates its own ability to cope. The treatments that followed from this explanation have focused almost entirely on the mind: therapy to reframe thinking patterns, medication to dampen the chemical reactions that produce fear, mindfulness practices to interrupt the cycle before it accelerates.

A meta-analysis published in Molecular Psychiatry by researchers at UC Davis Health has now identified something that none of those explanations account for. Across every type of anxiety disorder examined, across 25 separate studies involving more than 700 participants, one chemical difference showed up consistently in the brains of anxious people that was entirely absent in everyone else. Not a neurotransmitter imbalance. Not a structural abnormality. A measurable deficit of a single nutrient, concentrated precisely in the brain region responsible for emotional regulation, and almost certainly connected to something most people in the modern world are not eating enough of.

The nutrient is called choline. About 90% of US adults are not meeting their daily choline requirements. And the researchers say that in the brain, an 8% reduction is significant enough to matter.

The First Chemical Fingerprint of Anxiety

For decades, anxiety disorders have resisted the kind of biological characterization that has advanced understanding of other psychiatric conditions. Depression research identified serotonin and norepinephrine pathways decades ago, giving the field a molecular framework to build on even if that framework turned out to be incomplete. Anxiety has lacked an equivalent. Clinicians have known what anxious brains do behaviorally and functionally, but the underlying neurochemical signature that distinguishes an anxious brain from a non-anxious one has remained elusive.

The UC Davis team, led by Richard Maddock, a psychiatrist and research professor who spent decades treating patients with anxiety disorders, set out to fill this gap using magnetic resonance spectroscopy, a non-invasive brain imaging technique that measures the levels of specific metabolites inside living neural tissue without requiring any surgical access or injected tracers. The researchers analyzed data from 25 published datasets, comparing neurometabolite levels in 370 people with diagnosed anxiety disorders against 342 people without anxiety. They measured eight different brain metabolites including glutamate, GABA, creatine, and several others.

Seven of those eight metabolites showed no consistent difference between anxious and non-anxious brains. One did. Choline was about 8% lower in those with anxiety disorders, and the reduction was most clearly seen in the prefrontal cortex, the region involved in thinking, emotional regulation and decision-making.

“This is the first meta-analysis to show a chemical pattern in the brain in anxiety disorders,” said Jason Smucny, co-author of the study. The finding held across generalized anxiety disorder, panic disorder, social anxiety disorder, and phobias. Not one specific type of anxiety. All of them.

What Choline Actually Does in the Brain

To understand why a choline deficit in the prefrontal cortex would matter for anxiety, it helps to understand what choline is doing there in the first place.

Choline is an essential nutrient, meaning the body requires it to function but cannot produce sufficient quantities on its own. Most choline must be obtained through food, with the richest sources being meat, fish, poultry, dairy, and eggs. Inside the brain, choline serves two primary functions that are directly relevant to anxiety.

The first is structural. Choline is a critical component of phosphatidylcholine, the phospholipid that makes up cell membranes throughout the brain. Healthy, fluid cell membranes are essential for the efficient transmission of signals between neurons. When choline levels fall, membrane dynamics change, and the brain’s ability to process and transmit information becomes less efficient. Changes in choline levels measured by brain imaging reflect changes in membrane dynamics and phospholipid metabolism, which is precisely why the UC Davis researchers were looking at it as a window into brain function.

The second function is neurochemical. Choline is the direct precursor to acetylcholine, one of the brain’s most important neurotransmitters. Acetylcholine is essential for memory, mood regulation, attention, and the modulation of the stress response. When choline is insufficient, the brain has less raw material to produce acetylcholine, and the systems that depend on it for regulation begin to underperform.

The prefrontal cortex, where the choline deficit was most pronounced in anxious brains, is the region specifically responsible for top-down regulation of the fear response. It is the part of the brain that is supposed to assess a perceived threat, evaluate whether it is actually dangerous, and send calming signals down to the amygdala and brainstem circuits that generate fear. In anxiety disorders, this regulatory function is impaired. The prefrontal cortex loses its grip on the threat-detection system below it, and manageable situations begin to feel overwhelming.

A choline deficit in precisely this region creates a biological condition in which the regulatory hardware is running on depleted fuel. The prefrontal cortex cannot do its job at full capacity, not because it was built incorrectly, but because it is missing the nutrient it needs to maintain its own structure and produce the neurotransmitter that powers its regulatory function.

Why the Anxious Brain May Be Burning Through Choline Faster

One of the more nuanced findings from the research involves the relationship between anxiety and choline consumption in the brain itself. Norepinephrine is often elevated in anxiety disorders, and the UC Davis researchers suggest that this heightened arousal may increase the brain’s demand for choline.

This creates a self-reinforcing dynamic. Anxiety elevates norepinephrine, which increases the brain’s metabolic demand for choline. If dietary choline intake is already insufficient to meet baseline requirements, the additional demand created by chronic anxiety depletes reserves further. The prefrontal cortex, already struggling to regulate the fear response, loses even more of the nutrient it needs to do so. The deficit deepens, and the regulatory capacity weakens further.

This is not a clean linear relationship where more choline automatically means less anxiety. The research establishes correlation rather than causation, and the researchers are careful to note that clinical trials specifically testing choline supplementation in anxiety patients have not yet been conducted. But the biological logic of the pathway is coherent and grounded in established neuroscience. The question of whether restoring choline levels through diet or supplementation can shift the neurochemical balance in anxious brains is now a legitimate and urgent research question that this meta-analysis has opened.

The 90 Percent Problem

The statistic that gives this finding its full weight is a separate but directly relevant data point: about 90% of US adults are not meeting their daily choline requirements of 550 mg per day for men and 425 mg per day for women. This is not a marginal shortfall affecting a small subset of people with unusual diets. It is a near-universal nutritional gap in one of the most medically developed countries in the world.

The primary dietary sources of choline are foods that have been systematically reduced in modern Western diets. The richest sources include beef liver, eggs particularly the yolk, beef, chicken, fish, soybeans, and milk. Beef liver, the single most concentrated choline source available, is rarely eaten. Egg yolks, which deliver roughly 147 mg of choline per egg and nearly 30% of the daily recommended intake in a single serving, spent decades being avoided by health-conscious people due to concerns about dietary cholesterol that have since been substantially revised. The low-fat dietary advice that dominated nutritional guidance from the 1980s onward quietly gutted choline intake across the population while nobody was watching the neurological consequences.

The result is a population where 9 in 10 adults are running a choline deficit, and a new study showing that people with anxiety disorders have measurably lower choline in the exact brain region responsible for keeping anxiety under control. The overlap between these two facts is not subtle.

What This Means for Treatment

Richard Maddock spent decades treating patients with anxiety disorders before conducting this research. His assessment of the clinical implications is measured but direct. Anxiety disorders are the most common mental illness in the United States, affecting about 30% of adults. They can be debilitating for people, and many do not receive adequate treatment. The choline finding suggests that nutritional approaches may help restore brain chemistry and improve outcomes for patients, potentially alongside existing therapeutic and pharmacological interventions rather than instead of them.

This is not a claim that eating more eggs will cure anxiety. The pathway from dietary choline to brain choline levels to prefrontal cortex function to anxiety symptoms involves multiple biological steps, each of which will require dedicated clinical investigation to properly characterize. What the research does establish is that a consistent, measurable neurochemical deficit exists across all types of anxiety disorders, that this deficit sits precisely in the brain region most critical for anxiety regulation, that the vast majority of the population is already failing to consume adequate amounts of the nutrient in question, and that the biological mechanism connecting choline to anxiety regulation is well understood and mechanistically coherent.

For a condition that affects 30% of adults and is widely undertreated, having a nutritional hypothesis grounded in direct brain imaging data across 700 participants is not a small thing. It is a direction that clinical research now has a clear reason to pursue.

“An 8% lower amount doesn’t sound like that much,” Maddock said. “But in the brain, it’s significant.”

Source:

Maddock, R.J., Smucny, J. Transdiagnostic reduction in cortical choline-containing compounds in anxiety disorders: a 1H-magnetic resonance spectroscopy meta-analysis. Molecular Psychiatry, 2025; 30(12): 6020. DOI: 10.1038/s41380-025-03206-7 https://www.nature.com/articles/s41380-025-03206-7 https://health.ucdavis.edu/news/headlines/low-choline-levels-in-the-brain-associated-with-anxiety-disorders/2025/11